Pure Global
NCT06336993

Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP

Traditional Chinese Herbal Compound as Complementary Treatment for Non-specific Low Back Pain: A Randomized Controlled Trail Study
Zhejiang Provincial Tongde Hospital·Phase 4·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Low Back Pain
Drug/Device/Intervention
herbal compound
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Zhejiang Provincial Tongde Hospital
Location
Hangzhou, China
Timeline & enrollment
Phase
Phase 4
Start date
Jan 01, 2022
End date
Dec 15, 2023
Enrollment
71 participants
Primary outcome

Visual Analogue Scale,Oswestry disability index,Japanese Orthopaedic Association Scores

Summary

The aim of this randomized controlled trial was to explore the clinical efficacy and safety
 of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical
 outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP
 were recruited and randomly grouped to use TCM compound and celeoxib respectively for
 intervention. The pain status and lumbar function use scale of patients were scored before
 intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of
 patients after medication were recorded, and the clinical efficacy of the two groups of
 patients was compared finally.

ICD-10 classifications
Low back painPain in thoracic spineContusion of lower back and pelvisInjuries to the abdomen, lower back, lumbar spine and pelvisSprain and strain of lumbar spine
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06336993
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06336993 through Pure Global AI's free database. This Phase 4 trial is sponsored by Zhejiang Provincial Tongde Hospital and is currently Completed. The study focuses on Low Back Pain. Target enrollment is 71 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.